[1]唐志岚,牛志军,朱鹏展,等.新型冠状病毒肺炎与埃博拉病毒病流行病学特征及防控措施[J].西部中医药,2020,33(S1):36.
 TANG Zhilan,NIU Zhijun,ZHU Pengzhan,et al.Epidemiological Characteristics and the Measures of Prevention and Control for COVID - 19 and Ebola Virus Disease[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):36.
点击复制

新型冠状病毒肺炎与埃博拉病毒病流行病学特征及防控措施()
分享到:

《西部中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
33
期数:
2020年S1
页码:
36
栏目:
出版日期:
2021-06-30

文章信息/Info

Title:
Epidemiological Characteristics and the Measures of Prevention and Control for COVID - 19 and Ebola Virus Disease
作者:
唐志岚牛志军朱鹏展沈文
北京市宣武中医医院,北京100050
Author(s):
TANG Zhilan NIU Zhijun ZHU Pengzhan SHEN Wen
Xuanwu TCM Hospital, Beijing 100050, China
关键词:
新型冠状病毒肺炎埃博拉病毒病流行病疫情防控
Keywords:
COVID - 19 Ebola virus disease epidemic disease epidemic prevention and control
分类号:
R211 [
文献标志码:
A
摘要:
通过复习文献研究新型冠状病毒肺炎和埃博拉病毒病在病原学、流行病学、临床特点等方面的异同,发现两者在病毒特点、流行病学特征、临床表现等方面具有差异,因此提出了现阶段新型冠状病毒肺炎疫情防控要做好个人防护和隔离,加强医护人员防护,落实精准防控,发挥中医药防控优势。
Abstract:
The etiology, epidemiology, clinical features and others of COVID - 19 and ebola virus disease were studied through reviewing the literature, to find out the similarity and difference betwen both, therefore the measures of the prevention and control for COVID - 19 were raised at the current stage, we should do well in personal protection and isolation, enhance the protection for medical staffs, implement accurate prevention and control, and develop TCM advantages of protection and control.

参考文献/References:

[1] WHO.Ebola Virus disease democratic republic of the congo external situation report81[EB/OL].(2020-02-25)[2020-02-26].https://apps.who.int/iris/bitstream/handle/10665/331194/SITREP_EVD_DRC_20200225-eng.pdf.
[2] ZHU N,ZHANG D,WANG W,et al.A novel coronavirus from patients with pneumonia in China,2019[J].N Engl J Med,2020,382:727-733.
[3] LU R,ZHAO X,LI J,et al.Genomic characterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding[J].Lancet,2020,395(10224):565-574.
[4] BENVENUTO D,GIOVANNETTI M,CICCOZZI A,et al.The 2019 new coronavirus epidemic:evidence for virus evolution[DB/OL].BioRxiv,2020:1-13[2020-02-26].https://www.researchgate.net/publication/338810562_The_2019_new_Coronavirus_epidemic_evidence_for_virus_evolu-tion.
[5] PARASKEVIS D,KOSTAKI E G,MAGIORKINIS G,et al.Fullgenome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event[J].Infect Genet Evol,2020,79:1-12.
[6] ASCENZI P,BOCEDI A,HEPTONASTALL J,et al.Ebolavirus and marburgvirus:insight the filovirideae family[J].Mol Aspects Med,2008,29(3):151-185.
[7] 林迪,孙长贵.埃博拉病毒感染及其实验室检查[J].实验与检验医学,2014,32(5):495-497.
[8] 中华预防医学会新型冠状病毒肺炎防控专家组.新型冠状病毒肺炎流行病学特征的最新认识[J/OL].中华流行病学杂志,2020,41(2020-02-14)[2020-02-26].http://rs.yiigle.com/yufabiao/1181136.htm.
[9] 国家卫生健康委办公厅,国家中医药管理局办公室.新型冠状病毒感染的肺炎诊疗方案(试行第六版)[EB/OL].(2020-02-19)[2020-02-26].http://yzs.satcm.gov.cn/zhengcewenjian/2020-02-19/13221.html.
[10] HOLSHUE M L,DEBOLT C,LINDQUIST S,et al.First case of 2019 Novel Coronavirus in the United States[J].The New England Journal of Medicine,2020,382(10):929-936..
[11] LEROY E M,TELFER P,KUMULUNGUI B,et al.A serological survey of Ebola virus infection in central african nonhuman primates[J].J Infect Dis,2004,190(11):1895-1899.
[12] POURRUT X,DLICAT A,ROLLIN P E.Spatial and temporal patterns of zaire ebolavirus antibody prevalence in the possible reservoir bat species[J].J Infect Dis,2007,196(suppl2):176-183.
[13] PINZON J E,WILSON J M,TUCKER C J,et al.Trigger events:enviroclimatic coupling of Ebola hemorrhagic fever outbreaks[J].Am J Trop Med Hyg,2004,71(5):664-674.
[14] WEIGARTL H M,EMBURY-HYATT C,NFON C,et al.Transmission of Ebola virus from pigs to non-human primates[J].Sci Rep,2012,2:811.
[15] MARTIN-MORENO J M,LLINAS G,HERNANDEZ J M.Isrespiratory protection appropriate in the Ebola response?[J].Lancet,2014,384(9946):856.
[16] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流 行病学组.新型冠状病毒肺炎流行病学特征分析[J/OL].中华流行病学杂志,2020,41(2020-02-17)[2020-02-26].http://rs.yiigle.com/yufabiao/1181998.htm.
[17] 北京市卫生健康委员会.2月20日北京市新冠肺炎防控工作新闻发布会疫情通报[EB/OL].(2020-02-20)[2020-02-26].http://wjw.beijing.gov.cn/xwzx_20031/wnxw/202002/t20200220_1662905.html.
[18] World Health Organization.Novel Coronavirus disease(COVID-19) advice for the public:Myth busters[EB/OL].[2020-02-26].https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters.
[19] 吴朝学,涂文校,赵坚,等.利比里亚埃博拉病毒病流行特征分析[J].疾病监测,2015,30(10):886-890.
[20] 马飞飞,郭立春,杜道法,等.塞拉利昂埃博拉病毒病流行特征分析[J].疾病监测,2015,30(11):982-986.
[21] LIU W B,LI Z X,DU Y,et al.Ebola virus disease:From epidemiology to prophylaxis[J].Mil Med Res,2014,1(4):208-216.
[22] 杨涛,于晓娜,贺星星,等.新型冠状病毒肺炎早期临床表现 及肺部影像学分析[J/OL].中华急诊医学杂志,2020,29(2020-02-09)[2020-02-26].http://rs.yiigle.com/yufabiao/11-
80113.htm.
[23] VELASQUEZ G E,AIBANA O,LING E J,et al.Time from infection to disease and infectiousness for Ebola Virus Disease, a Systematic Review[J].Clin Infect Dis,2015,61(7):1135-1140.
[24] 李妍,徐胜勇,杜铁宽,等.2019新型冠状病毒肺炎临床特点及筛查流程探讨[J/OL].中华急诊医学杂志,2020,29(2020-02-12)[2020-02-26].http://rs.yiigle.com/yufabiao/11-
80577.htm.
[25] TONER E,ADALJA A,INGLESBY T.A primer on Ebola for clinicians[J].Disaster Med Public Health Prep,2015,9(1):33-37.
[26] 傅钢泽,许崇永,孙厚长,等.胸部CT检查在新型冠状病毒肺炎患者筛查中的应用[J/OL].温州医科大学学报,2020:1-9. (2020-02-20)[2020-02-26].https://kns.cnki.net/KCMS/detail/33.1386.r.20200219.1451.002.html.
[27] 向德栋,支轶,杨智清,等.5例埃博拉病毒病患者的临床特征分析[J].第三军医大学学报,2015,37(4):287-290.
[28] 程德忠,李毅.连花清瘟颗粒治疗54例新型冠状病毒肺炎患者临床分析及典型病例报道[J].世界中医药,2020,15(2):150-154.
[29] 杨海侠,张银萍,杨长虹,等.新型冠状病毒肺炎疑似患者留观隔离期的护理体会[J/OL].西部中医药,2020:1-3(2020-02-28)[2020-02-28].http://subject.med.wanfangdata.
com.cn/UpLoad/Files/202002/0c24900b7e384fec9a9bab1-d2c3a3289.pdf.
[30] 张燕琴,孔维维,禇晓霞,等.甘肃省第一批援鄂医疗队新型冠状病毒肺炎隔离病房护理管理体会[J/OL].西部中医药,2020:1-3(2020:03-10)[2020-03-12].http://subject.med .wanfangdata.com.cn/UpLoad/Files/202003/6581cdc783ab4f89abcbbec96e6bd83a.pdf.
[31] 曾建峰,李乐愚,缪灿铭,等.岭南道地药材在中山地区新型 冠状病毒肺炎防治中的应用[J/OL].西部中医药,2020:1-3(2020:03-10)[2020-03-12].http://subject.med.wanfangdata.com.cn/UpLoad/Files/202003/2500fc875275493cbc93f668c267f516.pdf.
[32] 桑天庆,周红光.中医药在新型冠状病毒肺炎疫情中的应用[J/OL].西部中医药,2020:1-3(2020:03-10)[2020-03-12].http://subject.med.wanfangdata.com.cn/UpLoad/Files/202003/09a2a1e25dd74da195925002ce98d661.pdf.

相似文献/References:

[1]李赟,王彩弟,王建云,等.简约远程中医诊疗在新型冠状病毒肺炎隔离病区中的应用[J].西部中医药,2020,33(S1):1.
 LI Yun,WANG Caidi,WANG Jianyun,et al.The Application of Simple Remote TCM Diagnosis and Treatment to COVID-19 Quarantined Inpatient Area[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):1.
[2]宋忠阳,雍文兴,张利英,等.新型冠状病毒肺炎的中医临床特征与辨证论治——甘肃经验*[J].西部中医药,2020,33(S1):3.
 SONG Zhongyang,YONG Wenxing,ZHANG Liying,et al.The Experience of TCM Clinical Characteristics, Syndrome Differentiation and Treatment for COVID-19 in Gansu Province[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):3.
[3]杜洪霖,马战平△.西北地区新型冠状病毒肺炎的中医特点及防治*[J].西部中医药,2020,33(S1):5.
 DU Honglin,MA Zhanping.TCM Characteristics, the Prevention and Treatment of COVID-19 in Northwest China[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):5.
[4]潘文,李盛华,王晓萍,等.中医对新型冠状病毒肺炎的认识与防治探讨[J].西部中医药,2020,33(S1):7.
 PAN Wen,LI Shenghua,WANG Xiaoping,et al.On TCM Understanding, the Prevention and Treatment of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):7.
[5]杨海侠,张银萍△,杨长虹,等.新型冠状病毒肺炎疑似患者留观隔离期的护理体会[J].西部中医药,2020,33(S1):13.
[6]丁潇,邹忆怀△,辛大永,等.北京顺义地区新型冠状病毒肺炎的中医临床证候与CT表现[J].西部中医药,2020,33(S1):16.
 DING Xiao,ZOU Yihuai,XIN Dayong,et al.TCM Clinical Syndromes and CT Manifestations of COVID-19 in Shunyi District of Beijing[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):16.
[7]桑天庆,周红光△.中医药在新型冠状病毒肺炎疫情中的应用[J].西部中医药,2020,33(S1):18.
 SANG Tianqing,ZHOU Hongguang.TCM Applied to Epidemic Situation of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):18.
[8]闫向勇,李 俊,燕忠生△.武汉地区新型冠状病毒肺炎中医证候及病机特点[J].西部中医药,2020,33(S1):20.
 YAN Xiangyong,LI Jun,YAN Zhongsheng.On the Characteristics of TCM Patterns and the Pathogenesis of COVID-19 in Wuhan Region[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):20.
[9]曾建峰,李乐愚,缪灿铭,等.岭南道地药材在中山地区新型冠状病毒肺炎防治中的应用*[J].西部中医药,2020,33(S1):24.[doi:10.1056/NEJMoa-2001017]
 and Treatment of COVID-9 in Zhongshan Region.The Application of Lingnan Genuine Drugs to the Prevention[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):24.[doi:10.1056/NEJMoa-2001017]
[10]朱玉,黎玉婷,姚德蛟△.从中西医不同角度分析麻杏石甘汤治疗新型冠状病毒肺炎的作用[J].西部中医药,2020,33(S1):26.
 of Traditional Chinese Medicine and Western Medicine.The Functions of Maxing Shigan Tang in the Treatment for COVID-19 from the Angles[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):26.
[11]唐志岚,牛志军,朱鹏展,等.新型冠状病毒肺炎与埃博拉病毒病流行病学特征及防控措施[J].西部中医药,2020,33(05):1.[doi:10.12174/j.issn.1004-6852.2020.05.01]
 TANG Zhilan,NIU Zhijun,ZHU Pengzhan,et al.Epidemiological Characteristics and the Measures of Prevention and Control for COVID-19 and Ebola Virus Disease[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):1.[doi:10.12174/j.issn.1004-6852.2020.05.01]

备注/Memo

备注/Memo:
收稿日期:2020-02-26 作者简介:唐志岚(1986—),女,硕士学位,主治医师。
更新日期/Last Update: 2020-03-19